Serum Institute defends Covid-19 vaccine pricing
The earlier price was based on advance funding and now it has to invest in scaling up and expanding capacity to produce more shots, the company says.
Full Article
Serum Institute defends Covid-19 vaccine pricing
Hindu
0 shares
3 views
You might like
Related news coverage
Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia
Oneindia
After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination..
-
Virus surge, vaccine shortages spread beyond India's borders
SeattlePI.com
-
Alarm grows in Africa as it watches India's COVID-19 crisis
SeattlePI.com
-
SII cuts vaccine price for states to Rs 300/dose, terms it a ‘philanthropic gesture’
IndiaTimes
-
Serum Institute reduces Covishield price for states from Rs 400 to Rs 300 per dose
IndiaTimes
Advertisement
More coverage
COVID-19: Covishield vaccine price for states reduced from Rs 400 to Rs 300 per dose
Zee News
As India gears up for the third phase of COVID-19 mass vaccination drive, the Serum Institute of India (SII) on Wednesday announced..
-
SII cuts price of COVID-19 vaccine Covishield for states from Rs 400 to Rs 300
DNA
-
Covid-19: US diverting raw material to Serum Institute for vaccine production
IndiaTimes
-
Serum Institute, Bharat Biotech asked to lower COVID-19 vaccine price: Official source
Zee News
-
Govt asks Serum Institute, Bharat Biotech to lower price of Covid-19 vaccines: Official sources
IndiaTimes